Creo Medical Group PLC buy krebskrebs
Start price
29.11.21
/
50%
€1.55
Target price
29.11.22
€2.00
Performance (%)
-72.13%
End price
30.11.22
€0.43
Summary
This prediction ended on 30.11.22 with a price of €0.43. The BUY prediction by krebskrebs for Creo Medical Group PLC performed very badly with a performance of -72.13%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Creo Medical Group PLC | -0.503% | -0.503% | 13.793% |
| iShares Core DAX® | -1.189% | -3.063% | 10.586% |
| iShares Nasdaq 100 | 3.663% | 8.732% | 34.914% |
| iShares Nikkei 225® | -1.422% | -0.414% | 3.883% |
| iShares S&P 500 | 2.182% | 4.907% | 28.279% |
Comments by krebskrebs for this prediction
In the thread Creo Medical Group PLC diskutieren
In the thread Trading Creo Medical Group PLC
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten